Actoverco - Official Website. LATEST PRODUCTSROSUREXINCONCORADANCOROMACORBION3. BION3. FEMIBION2. FEMIBION1. NEUROBIONEUTHYROXGLUCOPHAGETAMSOVERVIZARSINTIZANOVERZOLIVERNEURONTINQUENTIAXYASNALASENTRAALVENTAACTOCOLDXENOVERACTOPINACTOFEN EXTRAERIOPHOSRANOVERLETIZENULTOPNOLPAZAMETOVERACTOFERONACTOFERONInterferon beta 1b 3. Lyophilized vials, prefilled syringes of. Please read this leaflet carefully before you. Actoferon and each time your prescription is refilled since there. The information in this medication guide does not take. What is Actoferon? Actoferon is a type of protein called beta. It is used to treat relapsing. It will not cure your MS but may decrease the. MS is a lifelong disease that affects your. The way Actoferon works in MS is not known. Who should not take Actoferon? Do not take Actoferon if you have had an. Beta or human albumin. If you have depression, anxiety, trouble. Actoferon. If you become pregnant while taking Actoferon. Actoferon immediately and call your doctor. Actoferon may. cause you to lose your baby (miscarry) or may cause harm to your unborn child. This includes any vitamin. How should I take Actoferon? Actoferon is given by injection under the. Your injections should be approximately 4. If you miss. a dose, you should take your next dose as soon as you remember or are able to. What should I avoid while taking Actoferon? Sitemizde yer alan 11200 adet ilaç ile ilgili sayfalara buradan da eri
You should avoid becoming pregnant until you. You should also talk to your doctor if you are. What are the possible side effects of. Actoferon? Flu- like symptoms: Most patients have fever. You should talk to your doctor about taking. Skin reactions: Soreness, redness, pain. Depression and anxiety: There have been. If you. feel sad or hopeless you should call your doctor. Liver problems: If you develop symptoms of. Blood problems: You may have a drop in the. If the drop in levels are severe, they can lessen your. Thyroid problems: Your thyroid function may. Symptoms of changes in the function of your thyroid include feeling. Allergic reactions: Some patients have hives. Other patients. have more serious allergic reactions such as difficulty breathing and. Aspirin is a common medicine that has a number of uses, from relieving pain to reducing the risk of serious problems such as heart attacks and strokes. Indications contra-indications dosage side-effects pregnancy overdose identification patient information lacson syrup. Allergic reactions can happen after your first dose or may not. Actoferon many times. If you think you are having. Actoferon immediately and call your doctor. Whether you experience any of these side. Your doctor may want to monitor you more closely and ask you to have. Call your doctor for medical advice about. Instructions for Preparing and Giving. Yourself an Injection of Actoferon. Find a clean, flat working surface that is. You will need: One tray containing Actoferon. Make sure the. tray contains. Open the tray and take out all the. Check to make sure the rubber cap on the diluent syringe is firmly. Wash your hands thoroughly with soap and. Check the expiration date on the vial and. Do not use it if the medication. Reconstituting Actoferon. Take the cap off the Actoferon vial. Use an alcohol pad to clean the top of the. Move the pad in one direction. Leave the alcohol pad on top of the vial. Peel the label off the blister pack with. Remove the cap from the syringe and place. Remove the alcohol pad from the top of the. Actoferon vial. Place the syringe on top of the Actoferon vial and push down on. Actoferon vial. 6. Slowly push the plunger of the diluent. This will transfer all of the diluent in the syringe to. Actoferon vial. Continue to hold the plunger in during the mixing process. Gently swirl the vial to completely. Actoferon. Do not shake. Shaking can. cause Actoferon to. If there is. foam, allow the vial to sit undisturbed until the foam settles. After the cake is dissolved, look closely. If the mixture contains particles, or is discolored, do not. Verify that the vial is not cracked or damaged. Do not use cracked or. Preparing the Injection. You have. completed the steps. Actoferon and. are ready for. The injection should be given immediately after mixing. If you must delay giving yourself. Do not freeze. 1. With your thumb still pushing the plunger. Slowly pull the plunger back to withdraw. Actoferon vial into the syringe. Turn. the syringe assembly. Remove any air bubbles by tapping the outer wall of the syringe with. Slowly push the plunger to the 1 m. L mark on the syringe or to the. NOTE. If too much solution is pushed into the vial, repeat steps 1, 2, and 3. Turn the syringe assembly so that the vial. Remove the vial from the syringe. Remove the green needle from the syringe. Picking an Injection Site. Actoferon (Interferon beta 1b) is injected. The best areas for injection are where the skin is loose and soft and. Do not use the area near your navel or. If you are very thin, use only the thigh or outer surface of the arm. You should pick a different site each time. You should not choose the same area for two. Keeping a record of your injections will help. You should decide where your injection will. If there are any sites. Do not inject in a site where the skin is red. Let the skin area dry before you inject the Actoferon. Remove the cap. from the gray needle. Hold the syringe like a pencil or dart in one. Gently pinch the skin around the site with. While holding your skin, stick the. Slowly push the plunger all the way in until. Remove the needle. Gently massage the. Throw away the syringe in a disposal. Disposing of syringes and needles. Used. needles and syringes may be placed in a container made specially for. Do not use glass. You should always check with your healthcare. DO NOT throw the needle or syringe in the. Always keep the disposal container out of the reach. How should Actoferon be stored? Actoferon should be stored in 2. Actoferon and the diluent are for single use only. Unused. portions should be discarded. Rx Only ACTOVEXCIPRINOLFROMILIDSUPRIMUNEQUIN VAGINAL CREAMEQUINCYCLOGESTCyclogest. You may need to read it again.- If you have any further questions, ask your doctor, health care provider or pharmacist.- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, health care provider or pharmacist. What is in this leaflet. What Cyclogest is and what it is used for. Before you use Cyclogest. How to use Cyclogest. Possible side effects. How to store Cyclogest. Further information. What Cyclogest is and what it is used for. Cyclogest contains progesterone which is a natural, female sex hormone, produced in the body. Cyclogest works by adjusting the hormonal balance within the body for the treatment of: -pre- menstrual syndrome which often affects women during the 7 to 1. The symptoms of pre- menstrual syndrome include feelings of tension, irritability, depression, headache, breast tenderness, weight gain and bloatedness- post- natal depression which some women get after their baby has been born.- also be used for women who need extra progesterone while undergoing treatment in an Assisted Reproductive Technology (ART) programme. Before you use Cyclogesta. Do not use Cyclogest: - if you are allergic to progesterone or any of the other ingredients of this medicine (listed in section 6),- if you have known or suspected tumour that is hormone sensitive,- if you have porphyria disorders (a group of inherited or acquired disorders of certain enzymes), - if you have or have had blood clots in the legs, lungs, eyes or elsewhere in the body,- if you currently have or have had severe liver problems.- if you have a miscarriage and your physician suspects some tissue is still in the uterus or pregnancy outside of the womb. Take special care with Cyclogest. Talk to your doctor, health care provider or pharmacist before using Cyclogest. Take special care and tell your doctor straight away if you experience any of these symptoms during treatment or even few days after the last dosage: -pains in the calves or chest, a sudden shortness of breath or coughing blood indicating possible clots in the legs, heart, or lungs- severe headache or vomiting, dizziness, faintness, or changes in vision or speech, weakness or numbness of an arm or leg indicating possible clots in the brain or eye- worsening of depression. Check with your doctor or pharmacist before using Cyclogest if you have or ever have had: -liver problems such as jaundice (yellowing of the skin and whites of the eyes).- epilepsy- migraine- asthma- cardiac or renal dysfunction- diabetesc. Other medicines and Cyclogest. Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is especially important in case you are taking carbamazepine (e. Children There is no relevant use of Cyclogest in children. Pregnancy and breast- feeding. Cyclogest can be used during the first trimester of pregnancy for women who need extra progesterone while undergoing treatment in an Assisted Reproductive Technology (ART) programme. The risks of congenital (conditions present at birth) anomalies, including genital abnormalities in male or female infants, from exposure to exogenous progesterone during pregnancy have not been fully established. For other use, if you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. This medicine should not be used during breast feeding. How to use Cyclogest. Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. For women undergoing Assisted Reproductive Technology (ART) programme: The recommended dose is 4. Start using Cyclogest 4. The administration of Cyclogest should be continued for 3. For the treatment of premenstrual syndrome and post- natal depression: The recommended dose is 2. The pessary may be inserted into either the vagina or rectum (back passage) depending upon the following certain other conditions. You should insert Cyclogest into the. Such devices may not work properly in the presence of the vegetable fat from the pessary. Zentel Drug Information, Professional. Generic Name: Albendazole. VA CLASSIFICATIONPrimary: AP2. Commonly used brand name(s): Albenza. Note: For a listing of dosage forms and brand names by country availability, see Dosage Forms section(s). In addition, because albendazole is not commercially available in Canada, the use of the superscript 1 in this monograph reflects the lack of labeled (approved) indications for this medication. General considerations. Albendazole is a broad- spectrum anthelmintic. It is also used as an adjunct to surgery of hydatid cysts, either preoperatively or postoperatively, to reduce the risk of recurrence due to operative spillage. Mebendazole is preferred for the treatment of capillariasis. Mebendazole is preferred for the treatment of trichinosis. However, data to establish the efficacy of albendazole for this indication are limited. The loss of the cytoplasmic microtubules leads to impaired uptake of glucose by the larval and adult stages of the susceptible parasites, and depletes their glycogen stores. Degenerative changes in the endoplasmic reticulum, the mitochondria of the germinal layer, and the subsequent release of lysosomes result in decreased production of adenosine triphosphate (ATP), which is the energy required for the survival of the helminth. Due to diminished energy production, the parasite is immobilized and eventually dies. This action may be considered secondary to the effect on the microtubules due to the decreased absorption of glucose. This action occurs in the presence of reduced amounts of nicotinamide- adenine dinucleotide in reduced form (NADH), which is a coenzyme involved in many cellular oxidation- reduction reactions. However, albendazole is not recommended for use in pregnant women . Teratogenicity occurred in rats given oral doses of 1. In the rabbit study, maternal toxicity (3. However, no teratogenic effects were observed in mice given oral doses of up to 3. It is not known whether albendazole is distributed into human breast milk . However, problems in humans have not been documented. Pediatrics. Limited studies on the relationship of age to the effects of albendazole have been performed in children up to 6 years of age. Although hydatid disease is uncommon in infants and young children, no pediatrics- specific problems have been documented in infants and young children who were treated with albendazole for hydatid disease. In addition, five studies involving children as young as 1 year of age treated with albendazole for neurocysticercosis, which occurs more frequently than hydatid disease in children, did not document pediatrics- specific problems. However, no geriatrics- specific problems have been documented to date. Drug interactions and/or related problems. The following drug interactions and/or related problems have been selected on the basis of their potential clinical significance (possible mechanism in parentheses where appropriate)—not necessarily inclusive (» = major clinical significance): » Cimetidine (albendazole sulfoxide concentrations are increased in patients treated with cimetidine; increased concentrations are observed in bile and cystic fluid . Patients in whom intentional overdose is confirmed or suspected should be referred for psychiatric consultation. Patient Consultation. As an aid to patient consultation, refer to Advice for the Patient, Albendazole (Systemic) . In providing consultation, consider emphasizing the following selected information (» = major clinical significance): Before using this medication» Conditions affecting use, especially: Hypersensitivity to albendazole. Pregnancy—Not recommended for use in pregnancy because albendazole has been found to be teratogenic in animals; for women of childbearing age, taking the medication within 7 days after the start of normal menstruation; . Parasitologic and clinical relapse of giardiasis may occur after the completion of therapy; long- term follow- up with the physician may be necessary. Treatment may be repeated in three weeks. Treatment may be repeated as necessary. Treatment may be repeated in three weeks. Protect from freezing and direct sunlight. Treatment may be repeated in fourteen days. Up to three cycles of albendazole treatment may be given. Treatment may be repeated in fourteen days. Up to three cycles of albendazole treatment may be given. Protect from direct sunlight. USP dictionary of USAN and international drug names 1. Rockville, MD: The United States Pharmacopeial Convention Inc; 1. Zentel abbreviated prescribing information (Smith. Kline Beecham—UK), Rec 1/1. Eskazole prescribing information (Smith. Kline Beecham—UK), Rec 1/1. Goldsmith RS. Clinical pharmacology of the anthelmintic drugs. In: Katzung BG, editor. Basic and clinical pharmacology. Norwalk: Appleton and Lange; 1. WHO Model Prescribing Information: Drugs used in parasitic diseases. WHO, Geneva, 1. 99. Reynolds JEF, editor. Martindale: the extra pharmacopeia. London: The Pharmaceutical Press; 1. Markell EK, Voge M, John DT. Medical parasitology. Philadelphia: W. B. Saunders Company; 1. Van Reken DE, Pearson RD. Antiparasitic agents. In: Mandell GL, Douglas RG, Bennett JE, editors. Principles and practice of infectious diseases. New York: Churchill Livingstone, Inc.; 1. Jung H, Hurtado M, Sanchez M, Medina MT, et al. Clinical pharmacokinetics of albendazole in patients with brain cysticercosis. J Clin Pharmacol 1. Jan; 3. 2(1): 2. 8- 3. De Rosa F, Teggi A. Treatment of Echinococcus granulosus hydatid disease with albendazole. Ann Trop Med Parasitol 1. Oct; 8. 4(5): 4. 67- 7. Nies AS. Principles of drug therapy. In: Wyngaarden JB, Smith LH Jr, editors. Cecil's textbook of medicine. Philadelphia: W. B. Saunders Company; 1. Plorde JJ, Ramsey PG. Nematodes, cestodes and hermaphroditic trematodes. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, editors. Harrison's principles of internal medicine. New York: Mc. Graw- Hill Inc; 1. Monthly Index of Medical Specialties. London: Haymarket Publishing Services Ltd, 1. Feb: 1. 79. Open. Teggi A, Lastilla MG, De Rosa F. Therapy of human hydatid disease with mebendazole and albendazole. Antimicrob Agents Chemother 1. Aug; 3. 7(8): 1. 67. Meulemans A, Giovanangeli MD, Mohler J, et al. High performance liquid chromatography of albendazole and its sulfoxide metabolite in human organs and fluids during hydatidosis. J Liq Chromatogr 1. Ramalingam S, Sinniah B, Krishnan U. Albendazole, an effective single dose, broad spectrum anthelmintic drug. Am J Trop Med Hyg 1. Sep; 3. 2(5): 9. 84- 9. Pene P, Mojon M, Garin JP, et al. Albendazole: a new broad spectrum anthelmintic. Double- blind multi- center clinical trial. Am J Trop Med Hyg 1. Mar; 3. 1(2): 2. 63- 6. Steiger U, Cotting J, Reichen J. Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance. Clin Pharmacol Ther 1. Mar; 4. 7(3): 3. 47- 5. Todorov T, Vutova K, Mechkov G, et al. Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole. Ann Trop Med Parasitol 1. Feb; 8. 6(1): 5. 9- 6. Brown HW, Neva FA. Basic clinical parasitology. Norwalk: Appleton- Century- Crofts; 1. Macedo NA, Pineyro MI, Carmona C. Contact urticaria and contact dermatitis from albendazole. Contact Dermatitis 1. Jul; 2. 5(1): 7. 3- 5. Rossignol JF, Maisonneuve H. Albendazole: placebo- controlled study in 8. Trans R Soc Trop Med Hyg 1. Horton RJ. Chemotherapy of Echinococcus infection in man with albendazole. Trans R Soc Trop Med Hyg 1. Jan- Feb; 8. 3(1): 9. Takanayagui OM, Jardim E. Therapy for neurocysticercosis: comparison between albendazole and praziquantel. Arch Neurol 1. 99. Mar; 4. 9(3): 2. 90- 4. Del Brutto OH, Sotelo J, Aguirre R, et al. Albendazole therapy for giant subarachnoid cysticerci. Arch Neurol 1. 99. May; 4. 9(5): 5. 35- 8. Cruz M, Cruz I, Horton J. Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis. Trans R Soc Trop Med Hyg 1. Liu YH, Wang XG, Gao P, Qiang MX. Experimental and clinical trial of albendazole in the treatment of clonorchiasis sinensis. Chin Med J (Engl) 1. Jan; 1. 04(1): 2. Morgan UM, Reynoldson JA, Thompson RCA. Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. Antimicrob Agents Chemother 1. Feb; 3. 7(2): 3. 28- 3. Cline BL, Little MD, Bartholomew RK, et al. Larvicidal activity of albendazole against Necatur americanus in human volunteers. Am J Trop Med Hyg 1. Zhong HL, Cao WJ, Rossignol JF, et al. Albendazole in nematode, cestode, trematode and protozoan (Giardia) infections. Chin Med J (Engl) 1. Panel comment, 6/9. Panel comment, 6/9. Abramowicz M, editor. Drugs for parasitic infections. Med Lett Drugs Ther 1. Panel comment, 6/9. Panel comment, 6/9. Panel comment, 6/9. Panel comment, 6/9. Panel comment, 6/9. Hall A, Nahar O. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Trans R Soc Med Hyg 1. Jung H, Hurtado M, Medina MT, et al. Dexamethasone increases plasma levels of albendazole. J Neurol 1. 99. 0; 2. Kaminsky RG. Albendazole treatment in human taeniasis. Trans R Soc Trop Med Hyg 1. Chung WC, Fan PC, Lin CY, et al. Poor efficacy of albendazole for the treatment of human taeniasis. Int J Parasitol 1. Apr; 2. 1(2): 2. 69- 7. Barry M, Kaldjian L. Neurocysticercosis seminars in neurology. Semin Neurol 1. 99. June; 1. 3(2): 1. Open. Edlind TD, Hang TL, Chakraborty PR. Activity of the anthelmintic benzimidazoles against Giardia lamblia in vitro. J Infect Dis 1. 99. Panel comment, 7/9. Panel comment, 8/9. Botero D, et al. Short course albendazole treatment for neurocysticercosis in Colombia. Trans R Soc Trop Med Hyg 1. Sept; 8. 7(5): 5. Fourestie V, Bougnoux ME, Ancelle T, et al. Randomized trial of albendazole versus tiabendazole plus flubendazole during an outbreak of human trichinellosis. Parasitol Res 1. 98. USP Parasitic and Tropical Diseases Therapy Advisory Panel meeting recommendations, 1. Eskazole (Smith. Kline- Beecham). In: Walker G, compiler. ABPI Data Sheet Compendium 1. London: Datapharm Publications Limited; 1. Kollaritsch H, Jeschko E, Wiedermann G.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2017
Categories |